Immunovant
Price & Volume
Stats
See more52W Range | $12.72-$32.10 |
Market Cap | $2.7B |
Shares Short | 15M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$2.84 |
News
See moreYahoo Finance • 7 days ago
IMMUNOVANT INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Immunovant, Inc. - IMVT
Yahoo Finance • 21 days ago
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Yahoo Finance • 21 days ago
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Yahoo Finance • last month
Immunovant GAAP EPS of -$0.71
About
CEO | Dr. Eric Venker M.D., Pharm.D. |
Address | 320 West 37th Street, New York, NY, United States, 10018 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 362 |
